CAS 152459-95-5 appears in our catalog under these names: Imatinib, >95% (HPLC), Imatinib, Imatinib (STI571), Imatinib/ 99.85% (existing batch purity), Imatinib base. Offered by: TRC, Chemat Brand, Mikromol, Dr. Ehrenstorfer, GLPBio. Available pack sizes: 100mg, 1g, 500mg, on request, 10mM (in 1ml dmso), 5g, 200mg, 0,025kg.
Imatinib is a benzamide obtained by formal condensation of the carboxy group of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid with the primary aromatic amino group of 4-methyl-N3-[4-(pyridin-3-yl)pyrimidin-2-yl]benzene-1,3-diamine. Used (as its mesylate salt) for treatment of chronic myelogenous leukemia and gastrointestinal stromal tumours. It has a role as an antineoplastic agent, a tyrosine kinase inhibitor and an apoptosis inducer. It is a member of benzamides, a member of pyridines, an aromatic amine, a member of pyrimidines and a N-methylpiperazine. It is functionally related to a benzamide.
Source: ChEBI
| Molecular formula | C29H31N7O |
|---|---|
| Molecular weight | 493.6 g/mol |
| IUPAC name | 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide |
| InChIKey | KTUFNOKKBVMGRW-UHFFFAOYSA-N |
| SMILES | CC1=C(C=C(C=C1)NC(=O)C2=CC=C(C=C2)CN3CCN(CC3)C)NC4=NC=CC(=N4)C5=CN=CC=C5 |
Computed by PubChem (NCBI)